Naltrexone effects on subjective responses to alcohol in the human laboratory: A systematic review and meta‐analysis
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Naltrexone (NTX) has been widely studied for the treatment of alcohol use disorder with overall support for its efficacy. The mechanisms of action of naltrexone are thought to involve attenuation of the hedonic effects of alcohol and potentiation of its aversive effects. In order to provide a quantitative estimate of the effects of naltrexone on subjective response to alcohol, the aims of this meta‐analytic review are to examine the effects of naltrexone across four domains of subjective response. Meta‐analyses of naltrexone effects on alcohol craving (k = 16, N = 686), stimulation (k = 15, N = 675), sedation (k = 18, N = 777), and negative mood (k = 9, N = 281) suggested that under laboratory conditions and compared with placebo, naltrexone reduces craving (Hedges g = −0.252; SE = 0.054; 95% CI, −0.375 to −0.130; P < 0.01), reduces stimulation (g = −0.223; SE = 0.067; 95% CI, −0.372 to −0.074; P < 0.01), increases sedation (g = 0.251; SE = 0.064; 95% CI, 0.112‐0.389; P < 0.01), and increases negative mood (g = 0.227; SE = 0.047; 95% CI, 0.100‐0.354; P < 0.01). Results were robust when drinks per month and alcohol dose were added to the models as covariates. The effects of naltrexone varied by severity of alcohol use with medication effects on craving and stimulation being observed in sample of both heavy drinkers and AUD individuals. These results are consistent with the hypothesized mechanisms of action of NTX, although the effects are of small magnitude. This meta‐analysis aggregates across multiple human laboratory studies of NTX's effects on subjective response to alcohol, providing a comprehensive summary of a key mechanism of NTX efficacy, namely, alteration of the subjective experience of alcohol.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Simmons, J. P., Nelson, L. D., & Simonsohn, U. (2011) · Psychological Science · doi:10.1177/0956797611417632 · Cited by 6,567
Distribution Theory for Glass's Estimator of Effect Size and Related Estimators
Hedges, L. V. (1981) · Journal of Educational Statistics · doi:10.2307/1164588 · Cited by 5,695
Rehm, J., Mathers, C., Popova, S., Thavorncharoensap, M., Teerawattananon, Y., & Patra, J. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60746-7 · Cited by 3,870
Grant, B. F., Goldstein, R. B., Saha, T. D., Chou, S. P., Jung, J., Zhang, H., Pickering, R. P., Ruan, W. J., Smith, S. M., Huang, B., et al. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.0584 · Cited by 2,556
Morris, S. B., & DeShon, R. P. (2002) · Psychological Methods · doi:10.1037/1082-989x.7.1.105 · Cited by 2,502
Robust variance estimation in meta‐regression with dependent effect size estimates
Hedges, L. V., Tipton, E., & Johnson, M. C. (2010) · Research Synthesis Methods · doi:10.1002/jrsm.5 · Cited by 2,086
Analysing Data and Undertaking Meta‐Analyses
Deeks, J. J., Higgins, J. P., & Altman, D. G. (2008) · Cochrane Handbook for Systematic Reviews of Interventions · doi:10.1002/9780470712184.ch9 · Cited by 1,800
Beyond Power Calculations: Assessing Type S (Sign) and Type M (Magnitude) Errors
Gelman, A., & Carlin, J. (2014) · Perspectives on Psychological Science · doi:10.1177/1745691614551642 · Cited by 1,343
Undue reliance on I 2 in assessing heterogeneity may mislead
Rücker, G., Schwarzer, G., Carpenter, J. R., & Schumacher, M. (2008) · BMC Medical Research Methodology · doi:10.1186/1471-2288-8-79 · Cited by 1,287
Commentary: Heterogeneity in meta-analysis should be expected and appropriately quantified
Higgins, J. P. T. (2008) · International Journal of Epidemiology · doi:10.1093/ije/dyn204 · Cited by 995
Plasticity of reward neurocircuitry and the ‘dark side’ of drug addiction
Koob, G. F., & Le Moal, M. (2005) · Nature Neuroscience · doi:10.1038/nn1105-1442 · Cited by 963
Jonas, D. E., Amick, H. R., Feltner, C., Bobashev, G., Thomas, K., Wines, R., Kim, M. M., Shanahan, E., Gass, C. E., Rowe, C. J., et al. (2014) · JAMA · doi:10.1001/jama.2014.3628 · Cited by 923
Small sample adjustments for robust variance estimation with meta-regression.
Tipton, E. (2015) · Psychological Methods · doi:10.1037/met0000011 · Cited by 810 · cited 1×
“multiple related outcomes reported in a given study,(47-49) and (2) RVE methods are able to correct for small sample sizes that are common in behavioral pharmacology studies.(49) Given the significant methodological variation between studies, we expected a substantial degree of heterogeneity.”
BackgroundEffect of naltrexone on alcohol “high” in alcoholics
(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.4.613 · Cited by 308
robumeta: An R-package for robust variance estimation in meta-analysis
Fisher, Z., & Tipton, E. (2015) · arXiv · doi:10.48550/arxiv.1503.02220 · Cited by 280 · cited 1×
“Because these laboratory studies typically reported several outcomes within each SR domain, robust variance estimation (RVE) meta‐ analysis methods were implemented via the robumeta package in R.(47) RVE techniques were utilized as opposed to more traditional analytic methods for the following reasons: (1) RVE methods…”
MethodRay, L. A., & Hutchison, K. E. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.9.1069 · Cited by 258 · cited 1×
“Notably, genetic factors, including variants at OPRM1 loci, were not accounted for in this meta‐analysis and may clearly play a role in subjective responses to NTX in the laboratory.(33,87) Additionally, the present study relied heavily on US‐based studies, and recent work has suggested discrepancies in AUD pharmacoth…”
ResultSelf-citationNaltrexone-induced alterations in human ethanol intoxication
(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.10.1463 · Cited by 254
King, A. C., Volpicelli, J. R., Frazer, A., & O'Brien, C. P. (1997) · Psychopharmacology · doi:10.1007/s002130050156 · Cited by 227
Alcohol challenge responses predict future alcohol use disorder symptoms: A 6-year prospective study
King, A. C., McNamara, P. J., Hasin, D. S., & Cao, D. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.08.001 · Cited by 205 · cited 1×
“is the first study to quantify the magnitude of naltrexone effects on measures of alcohol reinforcement (ie, craving and self‐administration), no study has examined the putative mechanism of action of blunting hedonic responses to alcohol and/or potentiating aversive responses.(35,36) The importance of a quantitative…”
BackgroundWeerts, E. M., Kim, Y. K., Wand, G. S., Dannals, R. F., Lee, J. S., Frost, J. J., & McCaul, M. E. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301440 · Cited by 147
Drobes, D. J., Anton, R. F., Thomas, S. E., & Voronin, K. (2004) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000139704.88862.01 · Cited by 140
Anton, R. F., Drobes, D. J., Voronin, K., Durazo-Avizu, R., & Moak, D. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1720-7 · Cited by 135
King, A. C., Hasin, D., O’Connor, S. J., McNamara, P. J., & Cao, D. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.05.007 · Cited by 132 · cited 1×
“This is critical given that the higher severity and associated “dark side” of addiction is thought to represent a discrete phenotype characterized by a chronic and relapsing pattern of alcohol misuse with significant dysregulation of mood and stress systems(76,77), although it should be noted that efforts to character…”
ResultHeilig, M., Thorsell, A., Sommer, W. H., Hansson, A. C., Ramchandani, V. A., George, D. T., Hommer, D., & Barr, C. S. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.11.018 · Cited by 117 · cited 1×
“As a competitive opioid antagonist with primary affinity for μ‐opioid receptors, one proposed mechanism of action for naltrexone is the suppression of alcohol's rewarding subjective effects.(21,22) In support, a PET study found that naltrexone at the 50‐mg dose produced near complete inhibition of the μ‐opioid recepto…”
BackgroundRakap, S., Rakap, S., Evran, D., & Cig, O. (2016) · Computers in Human Behavior · doi:10.1016/j.chb.2015.09.008 · Cited by 80
Rueger, S. Y., McNamara, P. J., & King, A. C. (2009) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2009.00914.x · Cited by 78 · cited 1×
“is the first study to quantify the magnitude of naltrexone effects on measures of alcohol reinforcement (ie, craving and self‐administration), no study has examined the putative mechanism of action of blunting hedonic responses to alcohol and/or potentiating aversive responses.(35,36) The importance of a quantitative…”
BackgroundRay, L. A., Bujarski, S., MacKillop, J., Courtney, K. E., Monti, P. M., & Miotto, K. (2013) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2012.01916.x · Cited by 75
Self-citationThe effects of naltrexone among alcohol non-abstainers: results from the COMBINE study
Ray, L. (2010) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2010.00026 · Cited by 21
Self-citation
Cited by
Once-Weekly Semaglutide in Adults With Alcohol Use Disorder: A Randomized Clinical Trial
Hendershot, C. S., Bremmer, M. P., Paladino, M. B., Kostantinis, G., Gilmore, T. A., Sullivan, N. R., Tow, A. C., Dermody, S. S., Prince, M. A., Jordan, R., et al. (2025) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2024.4789 · Cited by 287
Turner, D., Briken, P., Grubbs, J., Malandain, L., Mestre-Bach, G., Potenza, M. N., & Thibaut, F. (2022) · Dialogues in Clinical Neuroscience · doi:10.1080/19585969.2022.2134739 · Cited by 86
The effect of neuroimmune modulation on subjective response to alcohol in the natural environment
Meredith, L. R., Grodin, E. N., Montoya, A. K., Miranda, R., Squeglia, L. M., Towns, B., Evans, C., & Ray, L. A. (2022) · Alcoholism: Clinical and Experimental Research · doi:10.1111/acer.14821 · Cited by 12
Self-citationPharmacological treatment for substance use disorder: A systematic review
Mateu-Mollá, J., Pérez-Gálvez, B., & Villanueva-Blasco, V. J. (2025) · Addictive Behaviors · doi:10.1016/j.addbeh.2024.108242 · Cited by 10
Metadata
- Authors
- Ray, L. A., Green, R., Roche, D. J. O., Magill, M., & Bujarski, S.
- Venue
- Addiction Biology
- Publisher
- Wiley
- Published
- 2019-05-30
- Volume
- 24
- Issue
- 6
- Pages
- 1138-1152
- ISSN
- 1355-6215 (ISSN-L)
- 1369-1600
- OpenAlex
- W2947444545
- Cited by
- 59
- References
- 28
- FWCI
- 1.45
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.